Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Milgrom

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bulletin De L'Academie Nationale De Medecine|October 15, 2003
[Recent data on the physiopathology of hyperthyroidism]Edwin Milgrom
Bulletin De L'Academie Nationale De Medecine|April 26, 2011
[Medical prevention of recidivism by sexual delinquents]Edwin Milgrom, Philippe Bouchard, Jean-Pierre Olié
The Journal of Biological Chemistry|January 17, 2003
Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1Anne Chauchereau, Larbi Amazit, Monique Quesne, et al.
Endocrine Reviews|August 31, 2002
Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiationMarkku Seppälä, Robert N Taylor, Hannu Koistinen, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
TSH receptor interaction with the extracellular matrix: role on constitutive activity and sensitivity to hormonal stimulationNicolae Ghinea, Catherine Baratti-Elbaz, Angelo De Jesus-Lucas, et al.
Cancer|March 26, 2003
Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomasGeri Meduri, Nathalie Charnaux, Frederique Spyratos, et al.
American Journal of Clinical Pathology|February 28, 2002
RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of boneSophie Roux, Larbi Amazit, Geri Meduri, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Mutation Ala(171)Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadismBeate Karges, Wolfram Karges, Manuele Mine, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2003
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Nicolas de Roux, Emmanuelle Genin, Jean-Claude Carel, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2005
Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activationBeate Karges, Stephane Gidenne, Chantal Aumas, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bulletin De L'Academie Nationale De Medecine|October 15, 2003
[Recent data on the physiopathology of hyperthyroidism]Edwin Milgrom
Bulletin De L'Academie Nationale De Medecine|April 26, 2011
[Medical prevention of recidivism by sexual delinquents]Edwin Milgrom, Philippe Bouchard, Jean-Pierre Olié
The Journal of Biological Chemistry|January 17, 2003
Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1Anne Chauchereau, Larbi Amazit, Monique Quesne, et al.
Endocrine Reviews|August 31, 2002
Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiationMarkku Seppälä, Robert N Taylor, Hannu Koistinen, et al.
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
TSH receptor interaction with the extracellular matrix: role on constitutive activity and sensitivity to hormonal stimulationNicolae Ghinea, Catherine Baratti-Elbaz, Angelo De Jesus-Lucas, et al.
Cancer|March 26, 2003
Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomasGeri Meduri, Nathalie Charnaux, Frederique Spyratos, et al.
American Journal of Clinical Pathology|February 28, 2002
RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of boneSophie Roux, Larbi Amazit, Geri Meduri, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Mutation Ala(171)Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadismBeate Karges, Wolfram Karges, Manuele Mine, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2003
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Nicolas de Roux, Emmanuelle Genin, Jean-Claude Carel, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2005
Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activationBeate Karges, Stephane Gidenne, Chantal Aumas, et al.
Pageof 2